1Lu-Gang Yu,The Henry Wellcome Laboratory of Molecular and Cellular Gastroenterology,Division of Gastroenterology,School of Clinical Sciences and Liverpool Centre for Glycobiology,University of Liverpool,Liverpool L69 3GE,United Kingdom.Circulating galectin-3 in the bloodstream:An emerging promoter of cancer metastasis[J].World Journal of Gastrointestinal Oncology,2010,2(4):177-180. 被引量：3
6[1]Randolph GW, Maniar D. Medullary carcinoma of the thyroid[J]. Cancer control, 2000,7(3) :253 - 260.
7[2]Modigliani E, Franc B, Niccoli-sire P. Diagnosis and treatment of medullary thyroid cancer[J]. Baillieres Best Pract Res Clin Endocrinol Metab, 2000,14(4) :631 - 649.
8[3]Leboulleux S, Travagli JP, Caillou B. Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course[ J]. Cancer,2002,94(1) :44 - 50.
9[4]Sanso GE, Domene HM, Garcia R. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers[J].Cancer, 2002,94(2) :323 - 330.
10[5]Hahm JR, Lee MS, Min YK. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases [ J ]. Thyroid,2001,11(1) :73 - 80.
